| Prev Close | 235.01 |
| Open | 235.94 |
| Day Low/High | 232.83 / 237.33 |
| 52 Wk Low/High | 224.02 / 281.16 |
| Volume | 348.23K |
Stryker Corporation (SYK)
235.96
0.95
0.40
NYSE
| Exchange | NYSE |
| Shares Outstanding | 378.15B |
| Market Cap | 88.22B |
| P/E Ratio | 52.05 |
| Div & Yield | N.A. (N.A) |
Covering These Shorts
I am covering some more of the following shorts: , , and .
Stryker Struck
Short position Stryker is being taken to the woodshed again. Down another -$9/share. Here's the bear case.
From The Street of Dreams
I am short Stryker . Credit Suisse and others on Wall Street seems to be coming towards my view on MAKO sales and a slowing growth rate for the company: Health Care Earnings Revising Estimates to Reflect Push of Robot Installs Into Q2, FX and Mgm...
Stryker's Choppy, Sideways Trading Pattern Is About to End
Here's what direction this medical device stock is about break.
Stryker
My Stryker short started poorly. But it has certainly started to improve recently. Small-sized, though I wish it was larger and I hadn't covered any of my short. Here's the bear case.
More Night Moves: A Quick Look at Overnight Futures
* The market (and money) never sleeps - and neither do I, it appears! * Futures had a very weak evening/early morning reflecting the China lockdowns, and not deepening concerns over Fed tightening as I suggested on Friday "Workin' on our night moves...
More SYK
I am covering more Stryker at $253. Now small-sized.
Updating Stryker
Stryker is trading lower in sympathy with Intuitive Surgical - trading lower on disappointing earnings.
Stryker
I covered some of my Stryker (-$10) short at $259.84.
New Buy (and Short) 'Levels'
* My revised levels I don't want there to be any ambiguity about the size of my positions, or about my buy and short levels, as I strive for as much transparency as possible. This column is a continued commitment towards that sort of disclosure. "Wh...
Shorts
Short positions - , , , , (newish) and - doing some heavy lifting on the downside!
SYK
The Bear case for Stryker .
Stryker
New short... Stryker . More to come this week.
More Big Deals for Health Care Eyed in 2022
As M&A investments could hit $400 billion this year, watch for buys in health technology and data, biotech, pharma and medical devices.
Surgical Device Maker Stryker Is Waiting to Move Higher
Let's review the charts and indicators.
Underperforming Transports, Vaccine Delivery, FOMC Statement, 3 Trading Thoughts
Wednesday afternoon the Fed's Federal Open Market Committee will publish the central bank's first official policy statement of 2021.
Big Tech's Big Night, Eyeing Amazon, My Kodak Moment, Powell's Blunt Assessment
The Fed has done a lot, and is willing to do even more, but for now, is watching Congress. The fiscal side is where the next shoe falls.
4 Ways to Invest in Robotics You Should Know About
Robots can't catch Covid-19, or anything else. While the rest of us stay home, they can keep factory output going with a minimum of human intervention.
Trading Volumes Rising, GDP Forecasts, Earnings and Trading Thoughts
Market leadership may be lacking on Thursday despite rising trading volumes, plus an update on Apple, Microsoft, Mastercard, Amazon and Gilead.
6 Testing, Diagnostics and Medical Devices Stocks You Should Know About
Look for weaknesses in companies like these that can provide solutions to today's pressing issues.
Stryker Shares Could Continue to Struggle in the Weeks Ahead
The stock of the medical device maker has been stagnant for months and its charts have yet to prove themselves.
6 Market Winds of Change, Trading Beyond Meat, GrubHub Earnings: Market Recon
If there was not a sizable addressable market for Beyond Meat, the competition would not be building as quickly as it is.
7 Medical Products Stocks With the Right Prescription for Gains
Top picks in the fast-growing medical products market.
SOX It to Me, Military Mischief in Asia, and Awaiting Amazon: Market Recon
And as the semiconductor sector continues to shine, Brooks Automation is a name to keep in mind.
Coming Up Short? Here Are Some Stocks to Consider
To effectively generate profits, a trader must pick several companies in a sector and short the whole bunch.
Early Morning Upgrades and Downgrades
Upgrades Dova Pharmaceuticals upgraded to Outperform from In-line at Evercore ISI Meridian Bancorp upgraded to Overweight from Neutral at Piper Jaffray; price target raised to $20 Landstar System upgraded to Mkt Perform from Underperform at Raymo...
The FANGs Ride Again, Plus Mercury Systems Rising: Market Recon
Netflix led the charge in FANG names. And why MRCY is now a hot stock in the defense sector.
Sloppy Earnings, China's Economy, AMD Earnings Preview: Market Recon
What we have seen of late from a number of chip producers really might be interpreted as pre-recessionary.
